Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does eliquis cause shortness of breath?Wegovy loss of exclusivity?What is the current stage of apotex's ruxolitinib generic development in the us?What is the success rate of lurbinectedin compared to traditional chemo in clinical trials?How can drowsiness from lipitor be managed?
See the DrugPatentWatch profile for zomacton
How does Zomacton differ from other growth hormones in its formulation? Zomacton is a recombinant somatropin that comes as a lyophilized powder requiring reconstitution before use. Many other growth hormone products arrive pre-mixed in pens or cartridges. The reconstitution step adds an extra procedure for patients or caregivers. When does the Zomacton patent expire? The active ingredient somatropin has long been off-patent, but formulation patents covering Zomacton’s specific reconstitution process and presentation remain in effect until at least 2026. Companies looking to launch biosimilars or generics must either bypass or challenge these claims. Can biosimilars enter the market before the Zomacton formulation patents expire? Yes. Some companies have announced plans to develop somatropin products that use alternative reconstitution methods or different presentation formats. These products bypass the specific IP held by the Zomacton manufacturer. Why are companies challenging the Zomacton patents? Manufacturers of competing growth hormones seek to access the sizable annual revenue still generated through Zomacton sales. Patent challenges often arise around the claimed reconstitution technique and presentation advantages, which are less unique than the molecule itself. How does Zomacton compare with Genotropin? Zomacton and Genotropin both use recombinant somatropin as their active ingredient. The difference lies mainly in delivery: Genotropin comes in a ready-to-use cartridge within a pen device, whereas Zomacton requires manual reconstitution. Patients who prefer convenience often choose Genotropin. What side effects are patients asking about for Zomacton? Patients report the gleichen side effects seen in other somatropin products: injection-site reactions, fluid retention, joint pain, and possible glucose intolerance. The pattern of complaints does not differ markedly from other growth hormone products. Who makes Zomacton? Ferinject GmbH, a subsidiary of CSL Behring, produces Zomacton. [1] DrugPatentWatch.com
Other Questions About Zomacton :